Search research articles
Contact Us
Filters
Showing results (11-20 of 234) with videos related to
Page
of 24
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
October 9, 2007
Emerging therapies for multiple sclerosis
Paolo A Muraro, Bibiana Bielekova
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 26, 2026
Should autologous HSCT be a first-line option in highly active MS: YES
Alice Mariottini, Paolo A Muraro
Trends in Immunology
|
January 13, 2006
Renewing the T cell repertoire to arrest autoimmune aggression
Paolo A Muraro, Daniel C Douek
Neurology
|
August 6, 2013
Premature immune senescence in children with MS: Too young to go steady
Amit Bar-Or, Paolo A Muraro
Current Opinion in Investigational Drugs (London, England : 2000)
|
December 16, 2010
Resetting autoimmunity in the nervous system: The role of hematopoietic stem cell transplantation
Paolo A Muraro, Sofia V Abrahamsson
Experimental Hematology
|
February 21, 2007
Optimized clonotypic analysis of T-cell receptor repertoire in immune reconstitution
Amy N Packer, Paolo A Muraro
Neurology
|
October 4, 2019
Complex intensive treatment shows promise against a complex aggressive disease
Paolo A Muraro, Jeffrey A Cohen
Multiple Sclerosis and Related Disorders
|
August 12, 2023
Should autologous hematopoietic stem cell transplantation be offered as a first-line disease modifying therapy to patients with multiple sclerosis?
Alice Mariottini, Paolo A Muraro, Riccardo Saccardi
Expert Review of Clinical Immunology
|
March 10, 2017
Progress and prospects for the use and the understanding of the mode of action of autologous hematopoietic stem cell transplantation in the treatment of multiple sclerosis
Fredrika Collins, Majid Kazmi, Paolo A Muraro
Allergy
|
July 22, 2014
Charting a research agenda for understanding the epidemiology of food allergy in adults in Europe
B I Nwaru, A Muraro, A Sheikh
Page
of 24
Search research articles
Search
Showing results (11-20 of 234) with videos related to
Sort By:
Page
of 24
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
October 9, 2007
Emerging therapies for multiple sclerosis
Paolo A Muraro, Bibiana Bielekova
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 26, 2026
Should autologous HSCT be a first-line option in highly active MS: YES
Alice Mariottini, Paolo A Muraro
Trends in Immunology
|
January 13, 2006
Renewing the T cell repertoire to arrest autoimmune aggression
Paolo A Muraro, Daniel C Douek
Neurology
|
August 6, 2013
Premature immune senescence in children with MS: Too young to go steady
Amit Bar-Or, Paolo A Muraro
Current Opinion in Investigational Drugs (London, England : 2000)
|
December 16, 2010
Resetting autoimmunity in the nervous system: The role of hematopoietic stem cell transplantation
Paolo A Muraro, Sofia V Abrahamsson
Experimental Hematology
|
February 21, 2007
Optimized clonotypic analysis of T-cell receptor repertoire in immune reconstitution
Amy N Packer, Paolo A Muraro
Neurology
|
October 4, 2019
Complex intensive treatment shows promise against a complex aggressive disease
Paolo A Muraro, Jeffrey A Cohen
Multiple Sclerosis and Related Disorders
|
August 12, 2023
Should autologous hematopoietic stem cell transplantation be offered as a first-line disease modifying therapy to patients with multiple sclerosis?
Alice Mariottini, Paolo A Muraro, Riccardo Saccardi
Expert Review of Clinical Immunology
|
March 10, 2017
Progress and prospects for the use and the understanding of the mode of action of autologous hematopoietic stem cell transplantation in the treatment of multiple sclerosis
Fredrika Collins, Majid Kazmi, Paolo A Muraro
Allergy
|
July 22, 2014
Charting a research agenda for understanding the epidemiology of food allergy in adults in Europe
B I Nwaru, A Muraro, A Sheikh
Page
of 24